Article in Nanoscale advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Li HuangDepartment of Thoracic Oncology, The Affiliated Hospital of Guizhou Medical University and the Affiliated of Cancer Hospital of Guizhou Medical University Guiyang 550004 China ouyangww103173@163.com.ORCID https://orcid.org/0009-0006-6729-2185
Xing ZhaoStem Cell and Tissue Engineering Research Center, Guizhou Medical University Guiyang 550004 China.
Jun ZhangDepartment of Pathology, The Affiliated Hospital of Guizhou Medical University and The Affiliated of Cancer Hospital of Guizhou Medical University Guiyang 550004 China.
Jiquan ZhangGuizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University Guiyang 550004 China.ORCID https://orcid.org/0000-0002-8034-7551
Weike LiaoGuizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University Guiyang 550004 China.
Yanhua FanGuizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University Guiyang 550004 China.
Jintian TangKey Laboratory of Particle and Radiation Imaging, Ministry of Education, Institute of Medical Physics and Engineering, Department of Engineering Physics, Tsinghua University Beijing 100083 China tangjt@mail.tsinghua.edu.cn.
Zhixu HeStem Cell and Tissue Engineering Research Center, Guizhou Medical University Guiyang 550004 China.
Fuping GaoKey Laboratory of Particle and Radiation Imaging, Ministry of Education, Institute of Medical Physics and Engineering, Department of Engineering Physics, Tsinghua University Beijing 100083 China tangjt@mail.tsinghua.edu.cn.
Weiwei OuyangDepartment of Thoracic Oncology, The Affiliated Hospital of Guizhou Medical University and the Affiliated of Cancer Hospital of Guizhou Medical University Guiyang 550004 China ouyangww103173@163.com.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Study on the therapeutic effect and some immune factors by methotrexate modified superparamagnetic nanoparticles in rat mammary tumors. · full record | OpenQuestion